FDA Panel Suggests Easing Rules on Controversial Peptides

WHO:

The Washington Post - The FDA committee, Health Secretary Robert F. Kennedy Jr.

WHAT:

The Washington Post - The FDA committee voted to recommend that certain pharmacies be allowed to produce at least one controversial peptide.

CBS News US - The FDA panel will review seven peptides to decide if they should be added to a list of substances that can be safely produced by compounding pharmacies.

WHY:

The Washington Post - The recommendation is part of Health Secretary Robert F. Kennedy Jr.’s efforts to promote peptides despite calls for caution from FDA researchers.

(UPDATED July 23, 2026 23:19 UTC)

The FDA committee has voted to recommend that certain pharmacies be allowed to produce at least one controversial peptide, a move that aligns with Health Secretary Robert F. Kennedy Jr.'s ongoing efforts to promote peptides. Additionally, the FDA panel is set to review seven peptides to determine if they should be added to a list of substances that can be safely produced by compounding pharmacies. This recommendation comes despite calls for caution from FDA researchers regarding the use of these substances.